NCT05872022View on ClinicalTrials.gov

A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy

Enrolling by invitationOBSERVATIONAL
Enrollment

728

Participants

Timeline

Start Date

July 5, 2023

Primary Completion Date

October 31, 2032

Study Completion Date

December 30, 2032

Conditions
PregnancyObesityOverweight
Interventions
OTHER

No Intervention

This is a non-interventional study, therefore no intervention is used.

Trial Locations (3)

08540

Novo Nordisk Investigational Site, Princeton

Unknown

Novo Nordisk Investigational Site, Madrid

Novo Nordisk Investigational Site, London

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY